Company / Net Debt per Share
ResMed Net Debt per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Debt per Share
-$3.75
FY2025
5-year range
-$3.75 / $8.22
FY2021-FY2025
Trend
-220.2%
vs FY2024
Sector context
#89 of 100
Health Care
What the data says
Net Debt per Share changed -220% YoY in FY2025, a notable deviation from the 9-year average annual change of +121%.
Based on SEC 10-K filings.
-3.75 in FY2025.
Improved from $8.22 to $-3.75 over the past 2 years.
Health Care sector context is included.
Net Debt per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 11% in Health CareTop 11% of 100This company -$3.75 Sector average $7.63
▼
-149.2% below sector average
Key checks
Key Insights
- In FY2025, net debt per share decreased 220.2% year-over-year.
- Ranks #89 out of 100 companies in the Health Care sector.
- Peak net debt per share was recorded in FY2023.
Company context
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Altman Z-Score 3.25 (safe zone, above 2.9 threshold)
- Strong profit margin: 27.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$3.75 | -220.2% |
| FY2024 | $3.12 | -62.0% |
| FY2023 | $8.22 | +143.5% |
| FY2022 | $3.38 | +40.5% |
| FY2021 | $2.40 | -50.8% |
| FY2020 | $4.88 | -37.4% |
| FY2019 | $7.79 | +1262.8% |
| FY2018 | $0.57 | -68.7% |
| FY2017 | $1.82 | +80.6% |
| FY2016 | $1.01 | +134.0% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026